Key structural requirements of benzamide derivatives for histone deacetylase inhibition: design, synthesis and biological evaluation

Narges Cheshmazar,Maryam Hamzeh-Mivehroud,Salar Hemmati,Hoda Abolhasani,Fatemeh Heidari,Hojjatollah Nozad Charoudeh,Matthes Zessin,Mike Schutkowski,Wolfgang Sippl,Siavoush Dastmalchi
DOI: https://doi.org/10.4155/fmc-2023-0122
2024-04-18
Future Medicinal Chemistry
Abstract:Background: Histone deacetylase inhibitors (HDACIs) are important as anticancer agents. Objective: This study aimed to investigate some key structural features of HDACIs via the design, synthesis and biological evaluation of novel benzamide-based derivatives. Methods: Novel structures, designed using a molecular modification approach, were synthesized and biologically evaluated. Results: The results indicated that a subset of molecules with CH 3 /NH 2 at R 2 position possess selective antiproliferative activity. However, only those with an NH 2 group showed HDACI activity. Importantly, the shorter the molecule length, the stronger HDACI. Among all, 7j was the most potent HDAC1-3 inhibitor and antiproliferative compound. Conclusion: The results of the present investigation could provide valuable structural knowledge applicable for the development of the HDACIs and benzamide-based antiproliferative agents in the future.
chemistry, medicinal
What problem does this paper attempt to address?